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Photopolymerizations are widely used in medicine to create polymer networks for
use in applications such as bone restorations and coatings for artificial implants. These
photopolymerizations occur by directly exposing materials to light in "open"
environments such as the oral cavity or during invasive procedures such as surgery. It
hypothesized that light, which penetrates tissue, could cause a photopolymerization
indirectly. Liquid materials could then be injected subcutaneously and solidified by
exposing the exterior surface of the skin to light. To test this hypothesis, the penetration
of UVA and visible light through swine and human skin fat and muscle was studied.
Kinetic modeling was used along with the light transmission data to predict the feasibility
of transtissue photopolymerization. To establish the validity of these modeling studies,
transdermal photopolymerization was applied to tissue engineering using "injectable"
cartilage as a model system. The ability to encapsulate chondrocytes was first studied in
vitro using poly(ethylene oxide)-dimethacrylate and poly(ethylene glycol). Biochemical,
histological and mechanical data demonstrated the formation of cartilage-like tissue.
Subsequently, polymer/chondrocyte constructs were injected subcutaneously and
transdermally photopolymerized. Implants harvested at 2, 4 and 7 weeks demonstrated
collagen and proteoglycan production and histology with tissue structure comparable to
native neocartilage. Finally, growth factors were incorporated into the
photopolymerizing hydrogel system in a controlled-release system using poly(lactic-co-
glycolic) acid microspheres. Insulin-like growth factor (IGF-1) and transforming growth
factor (TGF-b) were encapsulated with chondrocytes in vitro and produced significant
increases in proteoglycan and cell content. With further study, transdermal
photopolymerization could potentially be used to create a variety of new, minimally
invasive surgical procedures in applications ranging from plastic and orthopedic surgery
to tissue engineering and drug delivery.
Thesis Supervisor: Robert Langer
Germeshausen Professor of Chemical and Biomedical Engineering
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Chapter 1. Introduction
Medicine has moved toward minimally invasive procedures. Minimally invasive
procedures generally cost less, and more importantly have reduced patient morbidity.
This applies especially to the area of orthopedics. Joint related morbidity is a significant
problem in the general population. Over one million Americans are treated for cartilage
replacement. 1 It is estimated that 34 million Americans suffer from arthritis. 2 Younger
patients, in particular athletes, also suffer from cartilage destruction from trauma.
Previously researchers were interested in articular cartilage replacement using artificial
prostheses. Current research is focused on joint surface regeneration using techniques
including cartilage tissue engineering.
This thesis is concerned with development of a minimally invasive technique for
hydrogel implantation. While techniques for minimally invasive implantation have a
multitude of biomedical applications, this thesis examined applications in cartilage tissue
engineering.
Hypothesis
Photopolymerization has been extensively studied for a variety of applications
including dental implants. 3 Lasers and other light sources have gained popularity in
medicine in a variety of applications including phototherapy treatments. Phototherapy
treatments utilize light that penetrates the skin to stimulate photosensitive therapeutics. 4
The hypothesis for this thesis was that enough light would penetrate the skin or other
tissues to cause a photopolymerization in situ, through tissues. For example, a
prepolymer solution would be injected beneath the skin. The overlying skin would then
be exposed to light that would penetrate the skin to cause a polymerization, avoiding the
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need for an incision. This technique, transdermal photopolymerization, would thus
provide a method to implant hydrogels in a minimally invasive manner.
Hydrogels have a high water content, porosity and mechanical integrity similar to
natural biological tissues and matrix, making them an ideal candidate for tissue
engineering applications. 5 Furthermore, growth factors incorporated into the hydrogel
may potentially help to mimic natural extracellular matrix. It was hypothesized that a
combination of a polymerizing polymer and nonphotopolymerizing polymer, combined
to form a semi-interpenetrating network (semilPN), would provide a matrix for cartilage
development. The nonpolymerizing polymer is physically entrapped within the
polymerizing polymer. Poly(ethylene oxide) (PEO) was chosen as a model polymer
system with PEO-dimethacrylate (PEODM) as the photopolymerizing polymer with
entrapped PEO. In addition, the semiIPN would provide a two-fold degradation system,
with PEO quickly diffusing away to provide room for growing cells and the covalently
connected PEODM remaining to provide implant structural integrity.
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Specific Goals of the Thesis
1. Examine the potential for hydrogel implantation using transdermal
photopolymerization through in vitro analysis of light and various tissue samples. Cell
toxicity and photopolymerization kinetics will also be studied.
2. Analyze tissue forming potential of in vitro and in vivo encapsulation of chondrocytes
in photopolymerizing hydrogel.
3. Incorporate growth factors in the photopolymerizing hydrogel in a controlled fashion
to ameliorate tissue formation.
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Outline of Thesis Contents
A general introduction to photopolymerization and light in medicine is provided
in Chapter 2. The development of transdermal photopolymerization, toxicity analysis
and photopolymerization kinetics is described in Chapter 2. In vitro photoencapsulation
of chondrocytes was examined in Chapter 3, with both biochemical and mechanical
analysis. Chapter 4 applies transdermal photopolymerization and chondrocyte
encapsulation in vivo, examining tissue formation in athymic mice. Encapsulation of
cartilage growth factors in PLGA microspheres and their use with photoencapsulated
chondrocytes in the hydrogel are described in Chapter 5. Chapter 6 provides conclusions,
potential implications and prospective future studies.
1. Langer, R. & Vacanti, J., Tissue Engineering. Science 260, 920-926 (1993).
2. American Academy of Orthopedic Surgeons.
3. Decker, C., UV-Curing Chemistry: Past, Present and Future. Journal of Coatings
Technology 59, 97-106 (1987).
4. Kochevar, I., Photobiology. Dermatological Clinics 4, 171-179 (1986).
5. Peppas, N. Hydrogels in Medicine and Pharmacy, Vol. II CRC Press, Boca
Raton, FL, 1987.
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Chapter 2: Transdermal photopolymerization for Minimally Invasive
Implantation of Hydrogels*
2.1 Introduction
This chapter explores the use of transdermal photopolymerization as a method to
implant biomaterials in a minimally invasive manner using light that penetrates skin and
other tissues. The efficacy, toxicity and potential applications of transdermal
photopolymerization are examined. A general introduction to photopolymerizations and
the use of light in medicine is provided.
2.2 Background
2.2.1 In situ Photopolymerization. Fabricating polymers in situ provides many
advantages for a variety of biomedical applications. For example, pre-polymerized liquid
solutions or moldable putties can be easily placed in complex shapes (e.g., tooth caries)
and subsequently reacted to form a polymer of exactly the required dimensions (see
Section 2.2.3). Little, if any, additional shaping or modification of the implant is
required. The adhesion of the polymer to surrounding tissue is generally significantly
improved because of intimate contact of the polymer with the tissue during formation and
the mechanical interlocking that can result from surface microroughness. In addition to
these advantages, however, in situ polymerization also introduces many new challenges.
Polymerization conditions for in vivo applications are quite adverse, including a narrow
range of physiologically acceptable temperatures, requirement for nontoxic monomers
* This chapter was published in part in Proceedings of the National Academy of Sciences, 96:3104, 1999.
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and/or solvents, moist and oxygen-rich environments, the need for rapid processing and
clinically suitable rates of polymerization. However, photopolymerizations can
overcome many of these limitations. A photopolymerization occurs when a
photoinitiator and polymer (with groups sensitive to the initiating species) are exposed to
a light source specific to the photoinitiator species. In some cases the photoinitiator may
be attached to the polymer itself. Initiation of a photopolymerization does not require
elevated temperatures, and the polymerization process is typically rapid (a few seconds to
a couple of minutes), which allows the system to overcome oxygen inhibition and
moisture effects present in vivo (see Section 2.4.2).
The concept of using light to polymerize or cure materials in vivo has been
practiced in accessible places such as the oral cavity in dentistry, during invasive surgery,
and more recently through minimally invasive surgery, leading to potentially new
methods to prevent restenosis after angioplasty and post-surgical adhesions. 1-4 The
above approaches require directly shining light on polymers to cause a
photopolymerization, either as an open or invasive procedure. We hypothesized that
enough light might traverse tissue, including skin, to cause a photopolymerization
transdermally, and therefore provide a new method to implant biomaterials. Liquid
biomaterials could be delivered subcutaneously through a small diameter needle, and
would be converted from a liquid to a solid after only minutes of skin exposure to light
(Figure 2.1). Transdermal photopolymerization could effectively allow implantation of
biomaterials for plastic surgery applications, indluding both biodegradable and
nondegrading polymers, and would potentially enable cells or drugs to be injected and
encapsulated for tissue engineering, drug delivery or other applications. To test the
19
Trans mitted
Light
Water Soluble
Polymer Solution
Water Insoluble
Polymer Network
Figure 2.1. Schematic of transdermal photopolymerization demonstrating the
interactions of light with skin and photopolymerization.
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Figure 2.2. Methods of forming hydrogels: electronic, ionic or covalent interactions.
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concept of transdermal polymerization, a model polymer hydrogel system using
poly(ethylene oxide), PEO, was studied.
Hydrogels are candidate materials for many biomedical applications, including
tissue engineering and drug delivery because of their high water content, transport
properties, and tissue-like physical and mechanical behavior.5 Hydrogels are comprised
of polymer chains that are interconnected. The polymers may be connected through
electronic (e.g. hydrophobic) interactions, ionic interactions or covalent interactions as
depicted in Figure 2.2.
2.2.2 Light in Medicine. Light has made a significant impact in medicine and the
progression to minimally and non-invasive therapies. Clinical use of laser technology
has progressed with the development of small, inexpensive, and highly maneuverable
lasers. Light has replaced the scalpel in a variety of surgeries, including ear nose and
throat procedures, opthamology and plastic surgery. Thermal laser therapy (far infrared
carbon dioxide and near infrared lasers) are used for removing large tumors.6 Carbon
dioxide lasers may be used to destroy tumors in inaccessible areas such as the brain.
High precision eximer lasers are used for delicate surgeries to reshape the cornea. Near
infrared lasers introduced endoscopically are used for palliative tumor debulking in the
upper and lower gastrointestinal tract and large airways.7 In addition, treatment of solid
organ tumors has been examined. Using advanced imaging techniques (MRI, ultrasound
and CT), lasers can be carefully guided to ablate solid organ tumors.8 Solid tumors
treated using laser treament include hepatic metastasis, breast cancer and prostatic
hypertrophy and cancer.8, 9
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Lasers are particularly useful in the field of plastic surgery where minimally
invasive procedures reduce scarring. In particular, lasers can be used to cause
photocoagulation. Flash lamp pumped dye lasers are used to close small blood vessels,
removing port wine stains.6 Dermatologists have studied light penetration through the
skin to understand more about the development of cancers, including melanoma, and
photodermatosis (photoallergies).
The advent of phototherapy documented one of the first useful aspects of light
penetration through skin. UVA and visible wavelengths of light have shown themselves
beneficial in medical phototherapy due to their ability to penetrate human (or animal)
skin. Phototherapy utilizes penetrating light to activate photosensitive chemicals in the
skin. For example, psoralen, a photosensitive molecule, is used to treat psoriasis.
Porfimer sodium and meso-tetra hydroxyphenyl chlorin are photosensitizers used to treat
neoplasms in the oral cavity. 7  Antibody-targeted photolysis can also be used to
selectively target and kill cells.10 In addition to phototherapy, light provides beneficial
chemical reactions in the skin, most notably the synthesis of vitamin D that requires light.
The concept and development of transdermal photopolymerization emerged from the
understanding of light penetration through skin and the desire to implant materials in a
minimally invasive manner.
2.23 Photopolymerization in Medicine. While photopolymerizations have found many
applications in industry, including wood varnishes and coatings, it has an even longer
history in medicine. The first recorded medical use of light-induced polymerization was
over 4000 years ago when Egyptians placed bitumen of Judea, containing unsaturated
compounds, on linen strips for mummy preparation and subsequently placed the
23
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mummies in sunlight for hardening. 1 1 Today, the dental community is responsible for
extensive clinical use and research on photopolymerization.
Photopolymerizations are utilized in the field of dentistry for applications ranging
from sealants for carie prevention to root canal procedures. Resins are placed in caries
using photopolymerization. Bis-phenol-A-bis-(2-hydroxypropyl) methacrylate and
tri(ethylene glycol) are typical monomers used in resins. The photopolymerization
method is crucial to the successful restoration of the cavity to avoid resin shrinkage and
good bonding to the tooth dentin. 12 Photocurable liners that are placed with the resin
have been developed to aid resin bonding to the dentin. 13 Photopolymerizing resins are
also used to fill root canals. 14 Lasers in the 400-500 nm light regime are clinically
applied to photopolymerize in root canals. 14 , 15 In additional, argon lasers have been
coupled to optical fibers to allow photopolymerizations in endodontic therapy. 15
Research in photopolymerization of resins in root canals has examined the ability to
photopolymerize through dentin. A low level argon laser is capable of
photopolymerizing resin through millimeters of dentin from the root canal where a fiber
optic is introduced.1 5 Photopolymerization through dental ceramics has also been
examined. 16
New forms of light sources are being studied for the photopolymerization of
resins that may prove useful for transdermal photopolymerization with cells. Pulsed
lasers allow a more efficient photopolymerization that has a high conversion with less
energy. 12 , 17 Decreased energy exposure may prove useful in avoiding potential cellular
damage when using transdermal photopolymerization for tissue engineering purposes.
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Dentistry is also a good example of how photopolymerizations can be used to
duplicate complex anatomical shapes. Teeth have complex sulcular regions that are
difficult to duplicate. Research and clinical practice has shown how this complex
sulcular morphology can be formed using commercial photopolymerizing resins in
molds, providing functional and esthetic restorations. 18
2.3 Methods
2.3.1 Light Penetration. Skin was shaven and harvested from all regions of a swine
(Yorkshire, 6 months Massachusetts General Hospital). Fifteen samples of swine skin
were excised and hair and fat were removed. Six samples of muscle and fat each were
similarly prepared (approximately 1-cm squares). Eleven human cadaver skin samples
(Caucasian, National Institute of Disease Research) ranging in thickness from 1.35 mm to
2.55 mm were cut into approximately 1 cm squares and the subcutaneous fat was
removed. Tissue thickness was measured using a micrometer. Tissue hydration was
maintained by a saline bath. An integrating sphere was connected to two
monochromaters with a 75 W lamp (Spex Industries, Edison, NJ) as previously
described. 19 The integrating sphere reflects the penetrated light equally in all directions
so that the detector can then measure the intensity of the penetrated light at the
wavelength selected by the monochromater. Synchronous scans were performed from
250-550 nm with 2 nm increments, 0.1 s integration time, 1 mm slits and 0 nm offset.
The experimental apparatus is shown in Figure 2.3. Percent transmission was determined
by dividing the detected transmitted light with tissue by the lamp synchronous scan
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without tissue present (background). Linear regression analysis of light transmission
versus sample thickness was performed using Minitab Software.
2.3.2 Transdermal Photopolymerization Kinetics. Differential scanning calorimetry
(Perkin Elmer, DSC7 with a photocalorimetric accessory) was used to monitor the
polymerization rate of PEODM to determined kinetic constants. The photocalorimetric
accessory included a monochromator to select light of a given wavelength, as well as
neutral density filters to control the incident light intensity. Polymerizations were
monitored at 37 C in the presence of oxygen. In a typical experiment, 5-10 mg of the
poly(ethylene oxide)-dimethacrylate (PEODM, MW 3400, Shearwater Polymers, 20%
w/v in water) was placed in a DSC pan. A shutter was opened to expose the samples to
light of the selected intensity and wavelength and the polymerization rate was obtained.
A kinetic model developed and described elsewhere was used to predict the
polymerization rates and double bond (functional group) conversion during the
photopolymerization. 2 0 The model parameters were fit from the DSC rate data of
PEODM using the method of Anseth et al.2 1 Parameters used for both the UVA and
visible light simulation were as follows: kinetic constant for propagation, 105 L/mol-s;
monomer specific volume, 0.93 cc/g; polymer specific volume, 0.86 cc/g; thermal
expansion coefficient of monomer, 0.0005 / C, of polymer, 0.000075 / C; Tg monomer,
-100 'C; Tg polymer, 0 'C; concentration of initiator, 0.0025 M, monomer, 1 M. Visible
light simulations used a calculated intensity of 20.69 mW/cm2 (incident 100 mW/cm2),
initiator efficiency of 0.50 and fractional change in volume of 50 cc/g. UVA simulations
used a calculated light intensity of 0.045 mW/cm 2 (incident 100 mW/cm), an initiator
efficiency of 0.65 and a fractional change in volume of 150 cc/g. The kinetic model was
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kindly provided by Dr. Kristi Anseth, University of Colorado, Boulder, (see Appendix
A).
2.3.3 Cellular biocompatibility.
Mitochondrial metabolism. Primary bovine chondrocytes (preparation described in
Sections 3.3.1 and 4.3.1) were plated at a density of 1x10 4 cells/cc in 12-well tissue
culture plates. Control wells consisted of no initiator or light and initiator only. HPK
was added at desired concentrations from a stock solution (120 mg/ml). The plate was
exposed to 1.5 mW/cm2 UVA light for 2 minutes. After 24 hours media was removed
and 1 ml MTT (1 mg/ml, [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium
bromide]) was added and incubated for 1-3 hours. One ml of 0.04 N HCl in isopropanol
was added to the wells and mixed on a rotating shaker for 30 minutes. Absorbance was
read at 560 nm (n=3).
Lipid Peroxidation. Primary bovine chondrocytes were placed in 12-well plates at a
concentration of 1.5 millions cells/well. Each well contained 1 ml of media with 20%
(w/v) PEG (Polysciences, MW 100,000). PEG was added to help dissolve the
photoinitiator and to further duplicate the normal encapsulation procedure. Variables
included control (no light or initiator), light only, 0.04, 0.1, 1.0 and 5.0% (w/v)
photoinitiator 1-hydroxycyclohexyl phenyl ketone. Wells were exposed to 3 mW/cm 2
UVA light for 4 minutes. Two hundred microliters of cell supernatant was immediately
taken from each well and 8-iso-PGF2alpha was directly assayed from the cell culture
supernatant using an ELISA (R&D Systems).
2.3.4 Albumin release. A 5 % (w/w) loading dose of albumin was encapsulated in the
hydrogels. Bovine serum albumin (BSA, Sigma) was added to the 50/50% w/v
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macromer solution of MW 1000 and vortexed. One hundred fifty microliter aliquots of
albumin and polymer solution were placed in scintillation vials and photopolymerized 1
minute. Three millilters of PBS was added to the hydrogels. The gels (n=4) were
incubated statically at 370C. At various time points the PBS was removed and frozen
while 3 mL fresh PBS was added. Albumin concentration in PBS was determined using
a micro BCA assay (Pierce, Rockford, IL).
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Figure 2.3. Experimental setup to study the penetration of light through tissue.
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2.4 Results and Discussion
2.4.1 Light Penetration. The first feasibility issue for transdermal photopolymerization
involved the ability of light to penetrate skin. Human skin ranges in thickness from 0.5
mm over the tympanic membrane and eyelids to 6 mm on the back and soles of feet and
hands, with an average thickness of 1-2 mm.2 2 While light transmittance has been
examined in the stratum corneum and epidermis, few studies have focused on full
thickness skin including the dermis.19, 23 The penetration of light through full thickness
skin is imperative since implants are generally placed beneath the dermis or even
subcutaneous fat. The epidermis, typically only a fraction of 1 mm, contains
chromophores that absorb radiation and impede the penetration of light. Collagen present
in the dermis, which ranges in thickness throughout the body, is responsible for the
majority of light attenuation in full thickness skin. 19 , 23 Myoglobin in muscle and
carotenes in fat are also capable of absorbing light. Figure 2.4 demonstrates the
absorption of some common pigments found in animal tissues.
The transmittance of light through various tissue samples was analyzed from 300-
550 nm. Figures 2.5 shows representative absorption spectra obtained from skin, muscle
and fat samples analyzed from 300-500 nm. All tissues showed increasing light
transmittance as wavelength increased. Skin absorbed more light than muscle and fat.
Skin has developed methods (e.g., chromophores) to impede light penetration in order to
protect an organism from light damage, particularly shorter wavelengths that can cause
DNA and other damage. A peak of increased absorbance (or decreased light
transmission) is present at 400 nm and is compatible with the absorption spectrum of
hemoglobin. The hemoglobin peak is present in all of the tissue spectra. Thus it would
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Figure 2.4. Absorption of various biological pigments (Parrish, J.A. in The Science of
Photomedicine, eds. Regan, J.D. & Parrish, J.A., Plenum Press, New York, 1982).
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Figure 2.5. Transmittance of light through skin (---, 1.1 mm), muscle (-, 1.15 mm)
and fat (-, 1.2 mm) from 300-550 nm.
32
U- .~- -
I.-
~ I ~ I I ii
350 400 450 500 550
be practical to avoid light and photoinitiators in the 400 nm wavelength range where
hemoglobin will absorb light, decreasing transmittance.
The individual layers of the skin were separated to examine the individual
transmission properties of each layer. Stratum comeum alone transmits the majority of
exposed light (Figure 2.6). The dermis alone and full thickness skin samples demonstrate
similar transmissions. This implies that the dermis is responsible for the majority of light
attenuation in skin while the stratum corneum and epidermis readily allow light
transmission.
Spectra from tissue samples of varying thickness were compiled at 360 and 550
nm. Figures 2.7 - 2.9 demonstrate the transmission of light through skin, muscle and fat
respectively through tissue samples of varying thickness. The wavelengths 360 and 550
nm are in the ultraviolet (UVA) and visible light ranges respectively. Transmission data
from these two wavelengths were compiled from the scans because common
photoinitiators have maximal absorptions in these regions and they demonstrate bounds
where transmission is low (360 nm) and high (550 nm). All skin samples exhibited
decreasing light transmittance as tissue thickness increased and lower transmission in the
UVA region of light. The trends were linear and statisically significant as demonstrated
by regression analysis (Table 2.1)
Swine skin is often used as a model for human skin because of structural,
functional and biochemical similarities. 2 4-2 6 Swine and human skin transmission was
compared to verify the use of swine skin as a model for human skin. Longer wavelengths
of light were able to penetrate deeper through the tissue similar as shown in the previous
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Figure 2.6. Transmittance of light through swine a.) stratum corneum and
epidermis (-), b.) dermis alone (---, 1.99 mm) and c.) full thickness skin
containing stratum comeum, epidermis and dermis (-, 2.2 mm) from 300-550 nm.
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Figure 2.10. Transmittance of 360 (--1 --> and 550 (--s --> nm light through swine
subcutaneous fat of varying thickness.
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experiment, but the transmittance of human skin in the UVA region was markedly
reduced compared to swine skin (Figure 2.8). Negligible UVA light penetrated human
skin greater than 2 mm in thickness. Human and swine skin demonstrated similar
absorption in the visible light region analyzed (400-550 nm, Figure 2.8). Thus, swine skin
provides an appropriate model for light transmittance through human skin in the visible
light range only. The increased penetration of visible light, particularly in human skin,
suggests that the efficiency and toxicity of visible light photoinitiators should be
investigated for transdermal photopolymerization in humans.
2.4.2 Kinetics. The time required to transdermally photopolymerize a hydrogel under
skin was examined using a kinetic model for photopolymerization. Figure 2.11 portrays
the conversion versus time of PEO-dimethacrylate (PEODM, MW 3400) under 1.5 mm
human skin using visible or UVA light. A control reaction, with no skin present, is
shown using a UVA light source. An incident light intensity of 100 mW/cm 2 (used
clinically in phototherapy) and 0.04% (w/w) photoinitiator were used for the
simulations.27 UVA photoinitiators have a higher efficiency than visible light
photoinitiators, yet the penetration of visible light through human skin is greatly
enhanced compared to UVA radiation (Figure 2.11).28 The primary influence of light
attenuation in tissue is a decrease in polymerization rate and an increase in
polymerization time. While the conversion of PEODM beneath human skin using visible
and UVA radiation does not largely differ after 15 minutes (900 s), the visible light
polymerization reaches over 80 % conversion (and has formed a mechanically stable
network) after only 100 s of skin exposure to light. Even under skin with minimal light
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Regress bn p-values
360 nm 550nm
Skin 0.004 <04
Muscle 0.005 0.008
Fat 0.016 0.004
Table 2.1. Table of p-values for linear regressionanalysis of light penetration through
skin, muscle and fat.
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Figure 2.11. Kinetics of transdermal photopolymerization of PEODM with UVA (--),
visible light (? ) and beneath 1.5 mm human skin using UVA (--) and visible light (? )
using an incident light intensity of 100 mW/cm 2 and 0.04% (w/w) photoinitiator.
41
a.-
80
transmittance, polymerization times required for transdermal photopolymerization under
skin are short, clinically feasible times, on the order of minutes (Figure 2.12).
The effect of tissue thickness on polymerization time was determined using the
light transmission data from Figures 2.7 - 2.9 and the kinetic modeling program. Figure
2.12 shows the time required to reach 90% conversion under skin, fat and muscle of
varying thickness. This information will be useful for in vivo implantation using
transdermal photopolymerization. With knowledge of the desired depth of implantation,
the light exposure time required for polymerization can be determined
2.4.3 Cellular biocompatibility
Mitochondrial metabolism. To examine the cellular toxicity of transdermal
photopolymerization, we studied the effects of the activated photoinitiator on
chondrocyte (a model cell for tissue engineering) metabolism. The worst case scenario of
all radicals available to damage cells was examined by excluding the polymer, which
reacts with the radical species formed by photoinitiator exposure to light. Figure 2.13
demonstrates the effect of increasing photoinitiator concentration (HPK, 1-
hydroxycyclohexyl phenyl ketone) in complete media on cell metabolism as determined
by MTT activity located in the mitochondria and cytoplasm. A decrease in chondrocyte
MTT activity with increasing HPK concentration is observed after exposure of the cells
and initiator to light compared to controls (Figure 2.13). Low photoinitiator
concentrations (0.01-0.04% w/v) caused minimal chondrocyte damage, yet still allowed
photopolymerization to occur as demonstrated in the polymerization kinetics in Figure
42
2.11. These initiation conditions were subsequently utilized for optimal cell
encapsulation using photopolymerization.
43
1000
(s)
100
10
0 0.5 1 1.5 2 2.5
Thickness (mm)
3
Figure 2.12. Time required for 90% conversion under varying thickness swine skin (--i --),
muscle and fat (--0--) using an incident light intensity of 100 mW/cm2 and 0.04%
(w/w) photoinitiator.
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Figure 2.13. Normalized MTT absorbances of chondrocytes after exposure to 1.5
mW/cm 2 UVA light and HPK (% w/v). Control cells were not exposed to initiator or
light, HPK control (0.036% HPK) was not exposed to light and UVA control cells were
exposed to light only.
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Lipid Peroxidation. Initial biocompatibility studies used MTT to examine cellular
metabolism after exposure to the photoinitiator. These studies demonstrated that
increasing photoinitiator concentrations caused a decrease in cell viability although a
minimal photoinitiator concentration showed no difference from control cells. While
MTT provided an initial screening for photoinitiators, it is not a sensitive probe or
potential oxidative damage. The first region of a cell that a radical produced by a
photoinitiator in solution will encounter is the cell membrane. Lipids containing
arachidonic acid (e.g. present in the cell membrane and plasma) may undergo a free
radical-catalyzed reaction to form prostaglandin-F2 compounds.29 Furthermore, lipid
peroxidation caused by photoinitiators has been examined by groups in the dental
community.30, 31 Prostaglandin-F2 compounds have biological activity when released
from cells in vivo and can further react with cell components causing protein and DNA
oxidative damage. 3 2 The prostaglandin-F2 compounds are the source of the majority of
malondialdehyde that is capable of reacting with DNA and is measured in the
thiobarbituric acid test, the classic test for oxidative stress or damage.29 The formation
of prostaglandin-like compounds from arachidonic acid by oxidative stress is depicted in
Figure 2.14.
The chondrocytes exposed to the photoinitiator HPK exhibited higher levels of 8-
iso-PGF2alpha compared to control wells (Figure 2.15). The 0.04% wells produced
approximately four times the quantity of 8-iso-PGF2alpha. The 1.0% HPK wells
produced even more 8-iso-PGF2alpha while concentrations decreased in the 5 % HPK
wells. This decrease in 8-iso-PGF2alpha production with a higher concentration of HPK
may be caused by the decrease in cell viability (as demonstrated by the MTT results) and
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Figure 2.14. General reaction scheme of a lipid exposed to a radical. Adapted
from: "Free Radical Damage and its Control" in New Comprehensive
Biochemistry vol.28, eds. Rice-Evans, C.A. and Burdon, R.H.
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Figure 2.15. Concentration of 8-iso-PGF 2alpha in cell super-natent of chondrocytes
exposed to 0.04, 1 and 5 % HPK, light without HPK and controls exposed to neither light
or HPK.
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disruption of the cell membrane. Chondrocytes exposed to UVA light (without HPK)
had similar 8-iso-PGF2alpha levels to controls.
Potential radical cell damage may be overcome by various methods. Various
initiators and their toxicity can be examined. Furthermore, the initiator may be attached
to the macromer, limiting its mobility and potentially ability to react with cells. Post
polymerization and radical damage, various additives such as glutathione may be
provided in the hydrogel to promote repair of potential oxidative stress damage.
2.4.4 Tissue Biocompatibility. Hydrogels without chondrocytes were implanted via
transdermal photopolymerization to observe the tissue response to implantation and the
semiIPN. Figure 2.16 shows the skin, subcutaneous tissue and hydrogel in a mouse 3
days after implantation. No light damage, characterized by pyknotic nuclei, is observed
in the skin. The implanted polymer is surrounded by a fibrous capsule with inflammatory
cells (polymorphonuclear leukocytes, lymphocytes and giant cells), demonstrating a
foreign body response comparable to other biomaterials such as PGA. 3 3  These
experiments suggest biocompatibility of the transdermal photopolymerization process
and the hydrogel implant. Similar polymer hydrogels have been photopolymerized in
situ in clinical trials for adhesion prevention after surgery in the abdomen and as a sealant
in the lungs.3
2.5 Applications
One envisioned application for transdermal photopolymerization and simultaneous
photoencapsulation of cells is tissue engineering. A minimally invasive technique to
tissue engineer cartilage would provide many benefits in plastic surgery.
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Figure 2.16. H&E stained section of an implanted hydrogel (P, without cells), surrounded
by a fibrous capsule (C), subcutaneous tissue and skin (S).
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Figure 2.17. Release of BSA from PEODM (MW1000) hydrogels over 200 hours.
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For example, cell and macromer solutions could be injected underneath the skin, molded
to the desired shape, and subsequently photopolymerized circumventing the need for any
surgical incisions. The cartilage formed from the in situ molded and polymerized gel
would be beneficial for augmentation reconstructive surgeries. The potential of
transdermal photoencapsulation of chondrocytes for tissue engineering will be discussed
in Chapters 3-5.
In addition to the potential applications in tissue engineering, transdermal
photopolymerization may potentially be applied to the implantation of polymers for drug
delivery. Transdermal photopolymerization would allow physicians to implant polymer
delivery devices without the need for surgical intervention, thus providing an inexpensive
method with reduced risk to the patient and potentially newfound applications. In
contrast to methods that inject microparticles, these monolithic devices would potentially
have minimal migration, maintain localized delivery, and could be easily removed if
needed. As an illustration for this application, bovine serum albumin (BSA, MW 6800)
was photopolymerized in PEODM hydrogels (MW1000) and release was observed for
the duration of the experiment (Figure 2.17). In addition, other cell types may potentially
be encapsulated to secrete a drug or for engineering other tissues types.
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Chapter 3. In vitro Photoencapsulation of Chondrocytes in PEO-based
Hydrogels*.
3.1 Introduction
This chapter explores the ability to encapsulate chondrocytes in vitro in a
hydrogel using a photopolymerization. Current methods for encapsulating cells in gels
are reviewed. The production of collagen and glycosaminoglycans, the two major
components of cartilage extracellular matrix, was examined in order to demonstrate the
potential use of photoencapsulation for cartilage tissue engineering purposes.
3.2 Background
Tissue engineering has developed as a potential method to replace cartilage tissue
lost from trauma, tumor resection, congenital malformations or various disease
processes. 1 Cartilage tissue engineering has been an area of intense research due to the
lack of regenerative capacities of cartilage in vivo and the limited options currently
available clinically to replace cartilage structure and function. The tissue engineering
potential of a new scaffold or encapsulation system is often examined first in vitro to
observe cell responses in a controlled environment.
Cartilage is composed of chondrocytes distributed within an extracellular matrix.
The extracellular matrix is maintained by the chondrocytes and is comprised of
negatively charged proteoglycans, or glycosaminoglycans, which provide compressive
strength, and a collagen network that provides tensile strength.2 The purpose of tissue
* This chapter will be submitted in part for publication in a peer-reviewed journal
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engineering is to provide an environment and appropriate signals that will stimulate
chondrocytes to synthesize and form an organized extracellular matrix similar to native
cartilage. Current methods for tissue engineering cartilage use scaffolds, both synthetic
and biological, to create an environment to promote tissue formation. Scaffolds provide
important functions including mechanical support for developing tissue while allowing
for diffusion of nutrient and waste products. 3 In addition, scaffolds provide a matrix on
which cells may adhere and multiply as in the case of solid scaffolds, or physically entrap
cells in the case of liquid and gel scaffolds.
Both solid and liquid gel scaffolds have been studied as potential matrices for
cartilage tissue engineering. Solid scaffolds include poly(glycolic acid), PGA, meshes
which have been successfully used to engineer cartilage both in vitro and in vivo. 3
Recent attention has focused on engineered cartilage systems that can be injected in a
noninvasive manner for use in arthroscopic surgery. 4 A liquid scaffold system may be
injected arthroscopically or through a needle for subcutaneous implantation.
To design an injectable system, polymer scaffolds must be identified or developed
that are: i) water soluble to produce cell-polymer suspensions and ii) undergo a physical
or chemical change causing gelation after injection. Current gelling systems under
investigation include alginate, Pluronics, and fibrin glue. Alginate, a polysaccharide,
forms an ionic network in the presence of divalent or multivalent ions. Many groups
have investigated the activity and biological properties of chondrocytes entrapped in
alginate in vitro.5 Alginate has been examined in vivo for use in craniofacial cartilage
replacement and as cartilage plugs to prevent vesicoureteral reflux.6 , 7 Similarly,
chondrocytes have been encapsulated in agarose gels and the biochemical and
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mechanical properties of the resulting tissue has been studied. 8 Fibrin glue is another
biological gel which has been used to encapsulate chondrocytes but the resulting gel
degrades too quickly to maintain structural integrity before tissue is formed. 9
The purpose of this chapter is to analyze in vitro the potential of an injectable
polymer system that would encapsulate chondrocytes in a fast, controllable manner and
promote cartilage formation. Substituted poly(ethylene oxide) and a photopolymerization
process were utilized to transform a liquid, polymer solution to a gel. The biochemical
and mechanical properties of the resulting tissue were studied.
3.3 Methods
3.3.1 Cell Isolation. Saddle sections from 1-2 week-old calves were obtained from a
local abbattoir (A. Arena, Hopkington, MA). The intact femoropatellar groove was
removed and chondrocytes were immediately isolated using type II collagenase (0.2% in
complete media with overnight incubation, Worthington, Freehold, NJ), washed three
times with phosphate buffered saline (PBS) and passed through a Nytex filter. Ovine
chondrocytes were obtained from ovine saddle sections in a similar manner. Cell number
was determined by hemocytometer counting. Cells were centrifuged (1000 rpms, 10
minutes) to form a pellet prior to the addition of polymer.
3.3.2 Polymer Preparation. Poly(ethylene oxide), PEO (100,000, Shearwater Polymers,
Knoxville, TN) and poly(ethylene oxide)-dimethacrylate, PEODM (3400, Shearwater
Polymers) were combined in a 3:2 ratio and dissolved in PBS (phosphate buffered saline
with 100 U/ml penicillin G, 100 pig/ml streptomycin) to form a 20% (w/v) solution. The
photoinitiator 1 -cyclohexyl phenyl ketone (HPK, Polysciences) was added to the polymer
58
solution (3gl/ml polymer solution from a stock of 120 mg/ml in 70% ethanol). After
thorough mixing to dissolve the polymer, the solution was added to a pellet of
chondrocytes to make a final concentration of 50xI 06 cells/cc. The chondrocytes were
suspended in the viscous polymer solution by thorough mixing.
3.3.3 Photopolymerization. One hundred fifty microliters of the chondrocyte/polymer
suspension was placed in either sterile Eppendorfs or tissue culture inserts (diameter 6
mm) and placed under a UVA lamp for 3 minutes (Fig.3.1). The lamp was at a height so
that the polymer/chondrocyte solutions received a light intensity of approximately 2-3
mW/cm 2 as determined by radiometer measurements. Resulting hydrogels were
removed from the Eppendorf or tissue culture insert using a sterile spatula and placed in
12-well tissue culture plates with media (high glucose DMEM, 10% FBS, 10 jg/mi
vitamin C, 12.5 mM HEPES, 0.1 mM nonessential amino acids and 0.4 mM proline).
Media was refreshed biweekly. Hydrogels were incubated statically at 37 0C, 5% CO 2 .
Control hydrogels were synthesized and incubated as described above but contained only
polymer (without chondrocytes).
3.3.4 Biochemical Characterization. Hydrogels were analyzed by MTT ([3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide]) and light microscopy one
day after chondrocyte encapsulation. Three milliliters of MTT (0.5 mg/ml in DMEM
with 2% FBS) were added to hydrogels in 12-well plates. The hydrogels and MTT were
incubated for 2 hours. The MTT solution was removed and the hydrogels were rinsed
twice with PBS and micrographs (4.5X magnification) were obtained.
Biochemical analysis was performed on hydrogel constructs formed in , Eppendorfs
with bovine chondrocytes after 3, 7, 10 and 14 days of incubation. Hydrogels without
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cells were used as controls. Constructs were removed from the tissue culture plates,
blotted dry and wet weights (ww) were obtained. Gels were subsequently lyophilized for
at least 48 hours after which dry weights (dw) were determined. The hydrogels were
digested in 1 ml papainase overnight at 60'C. GAG content was estimated by
chondroitin sulfate using dimethylene blue dye and a UV-VIS spectrophotometer. 10
Total collagen content was determined by the hydroxyproline determined after acid
hydrolysis and reaction with p-dimethylaminobenzaldehyde and chloramine-T using 0.1
as the ratio of hydroxyproline to collagen. 1 1 The cell content of the hydrogels was
determined using Hoechst 33258, spectrofluorometry and a conversion factor of 7.7 pg
DNA per chondrocyte. 1 2
The polymer content of the hydrogel constructs was estimated from the biochemical
data. GAG and collagen contents (dry weights) were subtracted from the construct total
dry weight in order to estimate the polymer dry weight remaining in the constructs. The
remaining polymer is expressed as a percentage of the construct wet weight. Control
hydrogels (n=5) were synthesized as described, washed and vacuum dried to determine
original dry weight. The controls were then placed in media and incubated at 37'C.
Control polymer contents after incubation were determined from media sampling. All of
the media bathing the hydrogels was removed at specified time points and vacuum dried.
The weight of dried media alone was subtracted from the media samples of the
hydrogels. The amount of polymer present in the media was expressed as percentage of
the original hydrogel dry weight. One-way statistical analysis of variance (ANOVA) was
performed using Minitab.
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Histology was performed on hydrogels incubated for 2 weeks. The hydrogels
were preserved in 10% formalin and prepared according to standard histological
technique. Sections were stained with hematoxylin and eosin (H&E) and SafraninO.
3.3.5 Mechanical Characterization. Hydrogels were photopolymerized in tissue culture
inserts with ovine chondrocytes for mechanical analysis in order to form constructs in a
disk shape. 40% PEODM and 100% PEODM control gels without cells were prepared
the day before testing and allowed to swell overnight in PBS. Hydrogel constructs with
cells were incubated at 37 0C, 5% CO 2 and analyzed after 3 and 6 weeks of incubation.
Six-mm diameter disks were cored from the hydrogels that averaged approximately 7-8
mm in diameter. Thickness was measured by a current-sensing micrometer and was
generally on the order of 1.5 mm.
Mechanical and electromechanical properties were measured in uniaxial confined
compression in an apparatus described previously. 8 The equilibrium stress-strain
behavior was assessed by stepwise compressions of 10, 20 and 30% and load was
recorded for 15 minutes. After stress relaxation reached equilibrium at the 30% static
offset, a dynamic compression was superimposed at a frequency of 0.01-1 Hz. The
resulting oscillatory load and streaming potential were detected.
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Primary bovine chondrocytes
combined with polymer solution
Incubation in DMEM, 37C
Photopolymerization
Figure 3.1. Experimental Protocol: Cells isolated from articular cartilage were mixed
with poly(ethylene oxide)-dimethacrylate and poly(ethylene glycol) to a final
concentration of 50 x 106 cell/cc. Aliquots of the cell/polymer suspension were then
placed under 2 mW/cm 2 UVA light for 3 minutes and the resulting gels were incubated
under static conditions.
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3.4 Results
3.4.1 Cell Encapsulation. One day after photopolymerization, hydrogels grossly
demonstrated a uniform distribution of viable cells stained by MTT (Fig. 3.2). Upon
further examination by light microscopy a dispersion of cells within the hydrogel is
observed (Fig. 3.3). Clusters of two to three cells are observed although most cells are
individually dispersed. Heterogeneous chondrocyte morphology is observed with both
ovoid and elongated cells present.
3.4.2 Construct Composition. Constructs exhibited increases in total collagen and GAG
contents (% ww) from 3 to 14 days of static incubation (Fig. 3.4). The increases were
statistically significant (p<10 4 ). DNA content of the constructs decreased over the 14
days (Table 3.1, p=0.043). The polymer content of the control hydrogels declined during
the first week of incubation and then remained constant. Hydrogel constructs with cells
demonstrated a slower initial decrease in polymer content over the first week compared
to controls but a subsequent increased rate of degradation. (Fig. 3.5).
3.4.3 Mechanical Analysis. Construct mechanical and electromechanical properties
increased with time. Tissue engineered cartilage had significantly lower mechanical and
electromechanical properties than natural cartilage, generally on the order of one
magnitude below native cartilage (Fig. 3.6-8). The equilibrium modulus increased
steadily from an initial (40% PEODM control) value of less than 1 kPa to over 70 kPa
after 6 weeks of static incubation (Fig. 3.6). Control hydrogels synthesized using 100%
PEODM have a higher static equilibrium moduli compared to 40% PEODM semiIPNs.
The 100% and 40% PEODM gels show little difference in dynamic stiffness properties.
The dynamic stiffness of the constructs increases to a large degree after only 3 weeks of
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incubation compared to hydrogels and semiIPNs without cells (Fig. 3.7). A maximum
dynamic stiffness in the engineered cartilage of 1 MPa is observed after 6 weeks
incubation. The streaming potential of the constructs also increases with construct
incubation (Fig. 3.8).
3.4.4 Histology. The tissue structure of the photopolymerized hydrogel constructs
resembled cartilage (Fig. 3.9). The two-week constructs stained with H&E demonstrate
ovoid and elongated cells surrounded by a basophilic extracellular matrix (Fig. 3.9a). A
thin capsule (approximately one cell layer thick) is observed surrounding the cartilage-
like tissue that forms the bulk of the construct (Fig. 3.9a). Cells are present in varying
densities. Safranin-O clearly demonstrates the variation in cell distribution (Fig. 3.9b-d).
Figure 3.9b and c shows a region of hypercellularity with cells surrounded by a matrix
staining strongly for proteoglycans. Figure 3.9d demonstrates a region of the gel with
both small clusters and individual cells. The pericellular region of individual cells and
small clusters of cells stain for proteoglycans.
3.5 Discussion
Photopolymerization provides a fast, efficient method to convert a liquid to a gel in
situ under ambient conditions. 1 3 Photopolymerization is used extensively in the dental
community to form sealents on teeth and in caries. 14 Photopolymerization has also been
used in vivo to form gels for the prevention of tissue adhesions. 1 5 This technique
provides direct control of the polymerization process both temporally and spatially. For
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Figure 3.2. MTT staining of constructs one day after encapsulation demonstrate viable
chondrocytes (4.5X).
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Figure 3.3. Light microscopy of cells dispersed in the gel with both ovoid and elongated
morphology (1 OOX).
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Figure 3.4. Biochemical analysis: GAG and total collagen contents of constructs (% wet
weight).
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Time Cell Content
(days) (Millions of Cells/mg)
3 0.041 + 0.004
7 0.035 + 0.006
10 0.032 + 0.006
14 0.030 + 0.007
Table 3.1. DNA content of constructs.
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Figure 3.5. Polymer content (% dry weight) of control constructs without cells (--A--> and
cell constructs (-0--).
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Figure 3.6. Equilibrium moduli of control PEODM hydrogels and ovine constructs after
3 and 6 weeks of incubation.
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Figure 3.7. Dynamic stiffness of control PEODM hydrogels and ovine constructs after 3
and 6 weeks of incubation.
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Figure 3.8. Streamin potential of control PEODM hydrogels and ovine constructs after 3
and 6 weeks of incubation.
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A.) B.)
C.) D.)
Figure 3.9. Histological cross-sections of hydrogel constructs after 2 weeks incubation
stained with a.) hematoxylin and eosin, IOOX, b.) safranin-O/fast green demonstrating
proteoglycan distribution in a region of cartilage-like tissue, lOOX, c.) 200X and d.) a
region of sparsely distributed cells, 200X.
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example, the reaction or gelation process proceeds only when and where light is exposed
to the photopolymerizing polymer solution. Low concentrations of photoinitiator and
UVA light which are cell compatible, yet still allow photopolymerization to proceed
efficiently, can be used for cell photoencapsulation. The ability to encapsulate cells using
a photopolymerization process would provide a method to efficiently distribute cells in a
hydrogel system for tissue engineering or even drug delivery purposes.
High molecular weight poly(ethylene oxide) has been studied as an injectable
scaffold for cartilage tissue engineering in vivo. While cartilage-like tissue formed after
subcutaneous implantation in nude mice, the mechanical properties of the liquid polymer
solution were lacking before tissue was able to form. 16 Additionally, since no gel is
formed with PEO alone, in vitro study of the system is difficult. While in vivo studies
are important for clinical applications, in vitro analysis of a tissue engineering system is
desirable to avoid the influence and variability that animals add to a system.
Gels made from 40% PEODM were utilized for photoencapsulation of
chondrocytes. Through the addition of PEODM to the PEO system, a covalently
crosslinking network may be formed. 40% PEODM semilPNs provide some mechanical
strength with the covalent crosslinking, yet allow nutrient and waste transport and space
for tissue development with the uncrosslinked PEO. This polymer combination was used
as a model system for studying photoencapsulation of chondrocytes because of the
biocompatibility of PEO with chondrocytes. 1 6 Other photoreactive polymers or
polymer/initiator systems designed to influence cell movement or tissue formation could
potentially be used.
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Cartilage is composed of proteoglycans and collagen secreted by chondrocytes to
form a functional, organized extracellular matrix. Chondrocytes react to both the
biochemical and biomechanical signals provided in vivo to stimulate either matrix
synthesis or degradation. While proteoglycan and collagen concentration and
organization is heterogenous in native cartilage, measuring these matrix components
provides information regarding the proclivity of the chondrocytes to form cartilage-like
tissue within a particular scaffold or encapsulation system.
The concentration of both proteoglycans and collagen increased with incubation
time. Early time points (3, 7, 10 and 14 days) were studied in order to learn the initial
matrix production capabilities of the gel/chondrocyte constructs. Initial matrix deposition
is crucial to the survival and functionality of the constructs both in vitro where scaffolds
may be degrading and providing less support and in vivo where harsh mechanical forces
are present. The biochemical results show that the chondrocytes survive the
encapsulation process and that the gel scaffold allows for efficient chondrocyte matrix
production during the two weeks studied. While the GAG contents were similar to native
cartilage the collagen content was well below normal and other tissue engineered
cartilage. It may be hypothesized that with longer incubation times further matrix will be
produced and secreted. PGA scaffolds incubated in vitro showed continual increased
matrix production and organization for over 6 months of in vitro incubation. 3 If the
photopolymerizing gel system was injected in vivo, the presence of biochemical and
mechanical signals for matrix production may further enhance matrix production and
organization.
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The decrease in cell content observed in the first week of incubation may come
from a variety of sources. First, the cells were isolated from bovine femoropatellar
cartilage and used immediately. The stress of enzymatic isolation may be responsible for
some decrease in cell content. Second, the gel erodes during the first of incubation.
Little extracellular matrix has been deposited at this time so the cells may diffuse from
the construct along with the polymer.
The histology sections of the two-week hydrogels constructs also demonstrate
extracellular matrix production along with interesting morphological features (Fig. 3.9).
The safranin-O/fast green staining shows clearly large regions of cartilage-like tissue,
which appears to be hypercellular and secreting large amounts of proteoglycans. On the
other hand, there are also some regions that have small clusters and individual cells
staining for proteoglycans. The sparsely distributed cells appear viable and are secreting
matrix. Eventually, these clusters and individual cells may continue to grow and coalesce
to form a uniform matrix with further incubation. The high viscosity of the polymer
solution before gelation or the gelation process itself may be responsible for the
variations in cell density in the gel constructs.
Semi-interpenetrating networks, semiIPN, are comprised of both covalently
crosslinked PEODM and PEO physically entrapped within the PEODM gel. The PEO
can diffuse from semiIPN allowing space for extracellular matrix deposition or tissue
formation. While the PEO is able to diffuse from the hydrogels, the PEODM must be
degraded. Increasing the PEODM content of the semilPN increases the crosslinking
density or mechanical strength of the gel. The increase in crosslinking density may be
observed in both the decreased swelling of the hydrogels previously determined and the
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biomechanical properties found in this study (Fig. 3.6-8).17 The degradation of the
hydrogels was altered in the presence of the chondrocytes (Fig.3.5). Chondrocytes
produce esterases and other enzymes that may be responsible for the enhanced hydrogel
degradation. Complete degradation of the polymer is desirable for tissue engineering
cartilage so that only the desired tissue, in this case cartilage, is present.
The mechanical properties of tissue engineered constructs provides valuable
information on the functional and matrix properties of the tissue. Thus, biomechanical
data further aids in determining the tissue engineering potential of a scaffold system. It
has been demonstrated that the concentrations of GAG, collagen and water in cartilage
are related to the physical properties of the tissue. For example, it has been reported that
the equilibrium modulus increases with increasing GAG and decreasing water content. 18
The dynamic stiffness and streaming potential provide information regarding the total
matrix deposition and quality. 18 The increase in dynamic stiffness and streaming
potential with frequency is caused by the increasing fluid velocity in the constructs as
higher compression rates are applied. 8 In the case of dynamic stiffness, the observed
increase with time is due to the increased frictional interaction between the interstitial
fluid and matrix. The streaming potential is caused by the flow of fluid past immobilized
fixed charge. The majority of fixed charge (at physiological pH) is found on GAG. The
increasing streaming potential implies that GAG is being functionally immobilized into a
matrix in the gels. 8 The increase in the equilibrium modulus, dynamic stiffness and
streaming potential with time suggests that the encapsulated chondrocytes synthesized
functional extracellular matrix (Fig. 3.6-8).
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Chapter 4. In vivo Transdermal Photopolymerization of Chondrocytes
in PEO-based Hydrogels.*
4.1 Introduction
The previous chapter demonstrated the ability to encapsulate chondrocytes in a
photopolymerizing hydrogel in vitro. The encapsulated cells produced a functional
matrix suggesting their potential use of the photopolymerization system for tissue
engineering cartilage. The next step in studying the efficacy of transdermal
photopolymerization for clinical cartilage replacement is in vivo study. This chapter
addresses the tissue engineering of cartilage in athymic (nude) mice for up to 7 weeks.
4.2 Background
Reconstructive, orthopedic and plastic surgeons are continually faced with the
challenge of replacing cartilage lost by trauma, arthritis, or congenital abnormalities. 1
Due to limitations in the self-repair capability of cartilage, current therapies for cartilage
replacement include allogenic and alloplastic implants. These methods suffer from many
problems including lack of donor tissue availability, rejection, increased susceptibility to
infection and toxicity.2 Tissue engineering cartilage provides a method to replace lost
tissue with normal functional tissue. Tissue engineering of cartilage could potentially
provide a method to replace cartilage function in articular joints for orthopedic
applications and cartilage structure in plastic surgery.
* This chapter is in press for publication in Plastic and Reconstructive Surgery
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Tissue engineering has been defined as "the use of living cells, together with
extracellular components (natural or cellular) in the development of implantable parts or
devices for the replacement or restoration of function". 3 Specifically, cartilage has been
tissue engineered both in vitro and in vivo using a variety of biocompatible polymers
including poly(glycolic acid), (PGA). 1 PGA scaffolds have been seeded with
chondrocytes, incubated in bioreactors and then implanted subcutaneously in nude mice
or intra-articularly in rabbits. 2 , 4
Recently, new methods for minimally invasive injection of chondrocytes and
chondrocyte/polymer suspensions have been investigated. The injection of isolated
chondrocytes has been shown to promote cartilage repair. 5 In vivo injection of both a
scaffold and cells has been performed using calcium alginate, fibrin glue, and
poly(ethylene oxide), PEO as described in Chapter 4.6, 7 In contrast to injecting cells
alone, a scaffold provides a three-dimensional matrix on which the chondrocytes can
proliferate, produce matrix and form functional tissue in a desired shape. 8 The scaffold
may also provide mechanical stability for developing cartilage, particularly in joints
which are subjected to large forces.
An injectable gel system provides a method to non-invasively implant a polymer/cell
construct for cartilage tissue engineering. Noninvasive implantation of cartilage would
be highly advantageous for both orthopedic and plastic surgery applications. For
example, an injectable cartilage replacement system in the joint would prevent the need
for open surgery, requiring only orthoscopic surgery for implantation. Similarly, for
plastic surgery applications simply a needle injection and transdermal
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photopolymerization may be required as opposed to an incision. 5 The ability to
transdermally photopolymerize, or photopolymerize polymer and cells through the skin,
has been studied in vivo for applications in minimally invasive implantation and
craniofacial cartilage replacement. 5
Previously, viscous solutions of PEO and chondrocytes injected subcutaneously in
nude mice formed neocartilage. 7 While these results proved the efficacy of PEO in
supporting cartilage formation, the linear PEO chains diffused away rapidly and lacked
structural and mechanical integrity. Thus, to address these issues, we have utilized PEO
together with substituted PEO and photopolymerization to create a light-sensitive
gelation process that yields PEO scaffolds with improved structural integrity.
Photoinduced gelation provides spatial and temporal control during scaffold formation,
permitting shape manipulation after injection and during gelation in vivo. In addition to
designing a photoreactive scaffold for cartilage replacement, a minimally invasive,
transdermal photopolymerization technique was employed to implant the scaffolds,
allowing simply exposure of the skin surface to light in order to induce gelation of
scaffolds injected subcutaneously (Figure 4.1).9
4.3 Methods
4.3.1 Chondrocyte Isolation. Saddle sections from 2-4 week old bovine calves were
obtained from a local abattoir within 8 hours of slaughter. Articular cartilage from the
bovine femoropatellar groove was dissected and cut into small chunks and digested in
collagenase (0.2%) for 14-16 hours and poured through a nytex filter to isolate cells. The
cell suspension was centrifuged and washed with phosphate buffered saline (PBS) three
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Chondrocytes harvested from
calf femopatellar groove
Polymer-cell suspension
Four injection sites
beneath dermis of
nude mouse
Polymer solution Polymer exposed 
to light
Figure 4.1. Schematic of procedure for cartilage tissue engineering using transdermal
photopolymerization depicting i.) isolation of bovine chondrocytes from the
femoropatellar groove and combination with polymer (10-20% PEODM) to form ii.) a
polymer/ chondrocyte suspension. The polymer/chondrocyte suspension is subsequently
iii.) injected subcutaneously on the dorsal surface of a nude mouse and iv.) photo-
polymerized by placement of the mouse under an UVA lamp 3 minutes.
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SubQ Implantation: 2 wk .
10% PEODM
20% PEODM
30% PEODM
40% PEODM
4 wks 7 wks
Harvest: GAG
Collagen
DNA
Histology
Figure 4.2. Experimental Protocol.
84
-I
Figure 4.3. Athymic mouse undergoing transdermal photopolymerization under a low
intensity UVA lamp.
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Figure 4.4. Hydrogel implant post-photopolymerization.
86
Figure 4.5. 40% PEODM tissue-engineered constructs harvested after 7 weeks
implantation in a nude mouse.
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times. The primary chondrocytes were counted with a hemocytometer and added to a
polymer and PBS suspension to a final concentration of 50 million cells/cc.
4.3.2 Polymer Preparation. Poly(ethylene oxide)-dimethacrylate, PEODM, MW 3400
(Shearwater Polymers) and PEO MW100K were dissolved in PBS to make a 20% (w/w)
solution. The relative concentration of crosslinking polymer (PEODM) to linear polymer
(PEO) studied was 10:90 (10% PEODM), 20:80, 30:70, and 40:60 (40% PEODM)
PEODM:PEO. The photoinitiator, 1-hydroxycylcohexyl phenyl ketone (HPK,
Polysciences), was added to make a final concentration of 0.01% (w/w). The equilibrium
swelling constant of the hydrogels was determined using the following equation:
vs + Vp
VP
where vp is the volume of the polymer and v, is the volume of solvent (water) present
within the hydrogel when swollen. Hydrogels were formed after exposure of 10-40%
PEODM/PEO polymer solutions (150 tl aliquots each) to UVA light for 4 minutes. The
resulting semi-interpenetrating networks (semiIPNS) consisted of both crosslinked and
uncrosslinked PEO. Gels were swollen in PBS for 3 hours to determine the water
content. The gels were lyophilized to obtain the dry weight and subsequent volume of
polymer.
4.3.3 Implantation and Harvest. Twelve athymic female mice (Charles River
Laboratories, Massachusetts General Hospital) were anesthetized with methoxyfluorane
and injected with polymer/chondrocyte suspension. Each mouse received one aliquot
(0.12 ml) from each of the four polymer compositions (10, 20, 30, 40% PEODM).
Control mice comprised of injections of polymer alone (40% PEODM). Following
88
injection mice were placed 2 inches below a UVA lamp (GloMark Systems) to permit
exposure to an intensity of 2 mW/cm 2 for 3 minutes as measured by radiometer. The
polymer/chondrocyte hydrogel was palpated to observe the progression of
polymerization. Four mice were sacrificed at 2, 4 and 7 weeks by pentobarbitol
overdose. To determine the relative amounts of collagen type I and type II formed in the
constructs, seven additional mice were injected with four 0.1 ml aliquots of 35% PEODM
and 50 million cells/cc and photopolymerized as described above. The mice were
sacrificed after 6 weeks (7 mice, 28 constructs). All constructs were carefully removed
and weighed to obtain the implant wet weight.
4.3.4 Construct Analysis. Constructs were dried under vacuum for at least 24 hours after
which dry weights were obtained. The dried constructs were subsequently digested by
addition of 1 ml of papain solution (125 ptg/ml Papain, 100mM phosphate buffer, 10mM
cysteine, 10mM EDTA, pH 6.3) and incubated in a water bath at 60'C for 16 hours. The
concentration of chondroitin sulfate was determined using the DMMB dye assay as
previously described. 10 Total collagen content was determined by hydroxyproline
content, as previously described. 1 1 The DNA content of the constructs was determined
by the Hoechst dye method and cell number was calculated using the conversion factor of
7.7 pg DNA/chondrocyte. 12 Results are given as average and standard deviation (n=4).
Statistical analysis was performed using Minitab Software. Time and % PEODM were
the two factors studied using a randomized complete block design and ANOVA analysis.
The ratio of collagen type I and II was determined for 35% PEODM constructs and
three bovine articular cartilage control samples.1 3 Constructs for collagen analysis were
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digested in formic acid (70%) for 1 hour at 60'C followed by overnight incubation at
room temperature in CNBr (0.55 g/ml) in formic acid. After drying, the samples were
redissolved in reducing sample buffer (Owl Separation Systems) and incubated at 80'C
for 10 minutes. Approximately 50 pg of digested collagen was added to each lane in a
15% polyacrylamide gel. The gel was run at 100 V for 1.5 hours, stained with
Coomassie blue for 45 minutes and destained overnight. The ratio of CB 10 and CB 11
collagen peptide fragments were analyzed using NIH Image. 13
4.4 Results
4.4.1 Polymer. The equilibrium swelling constant, or equilibrium swelling volume ratio,
of the PEODMIPEO semi-IPNs are given in Table 4.1 along with gross observations of
the gels. The 10 and 20% PEODM networks dissolved completely in PBS therefore no
swelling could be observed. The 30% and 40% PEODM networks exhibited an
equilibrium swelling volume of 16.89 and 16.02 respectively, both increased compared to
100% PEODM networks which had an equilibrium swelling constant of 9.81.
4.4.2 Biochemistry. The biochemical composition of the neocartilage formed was
analyzed as a function of polymer matrix composition (10, 20, 30 and 40% PEODM) and
time (2, 4, and 7 weeks). Harvested implants (40% PEODM, one-month implantation)
are shown in Figure 4.5. Grossly, constructs are avascular and opaque, characteristics of
native cartilage. Biochemical results are described in Figures 4.6 and 4.7. The
glycosaminoglycan, GAG, contents at 7 weeks ranged from 2.8% per cohistruct wet
weight in the 10% PEODM hydrogels to 1.5% per wet wt. in the 40% PEODM hydrogels
(Figure 4.6). GAG content decreased with increasing % PEODM (p<10 4 , Table 4.3).
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Equilibrium Swelling
% Constant Gross
PEODM Q Observations
10 dissolved -
20 dissolved -
30 16.89+4.72 opaque/white
40 16.02 + 1.27 opaque/white
100 9.81 + 0.58 clear
* Values are average + standard deviation (n=4)
Table 4.1. Equilibrium swelling constants and physical characteristics observed in semi-
interpenetrating networks/gels of varying % PEODM.
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Figure 4.6. The percentage of GAG per construct wet weight over time in hydrogels of
varying PEODM concentration.
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Figure 4.7. The percentage of collagen per construct wet weight over time in hydrogels
of varying PEODM concentration.
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Figure 4.8. SDS-PAGE gel to determine the Collagen II/I ratio in 35% PEODM
constructs harvested after 6 weeks and control bovine articular cartilage.
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M
Tissue Engineered
(2
DNA Content
(millions of cells/mg wet weigi
% PEODM 2 weeks 4 weeks 7 weeks
10 0.021 + 0.0021 0.034 + 0.015 0.02 + 0.0024
20 0.018 + 0.0018 0.016 + .0063 0.018 +0.0063
30 0.037 + 0.0042 0.025 + 0.0075 0.015 + 0.016
40 0.028 + 0.0019 0.016 + 0.0027 0.023 + 0.0041
Table 4.2. DNA content of hydrogels with varying % PEODM at 2, 4 and 7 weeks.
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Factor SS MS F p
Time GAG 2.99 1.49 7.01 0.003
Collagen 53.47 25.74 40.66 <10 4
DNA 3.15x10~4 1.58x10~4  1.06 0.36
% PEODM GAG 7.6 2.53 11.88 <10'
Collagen 5.26 1.75 2.66 0.067
DNA 2.07x10 4 6.88x10~5 0.46 0.71
Table 4.3. Statistical analysis of biochemical data. SS = Sum of Squares, MS = Mean of
Squares, F = Variance Ratio used to determine the probability (P) from a Fischer Table.
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The total collagen content of the 10% PEODM hydrogel was 5% per wet weight at 7
weeks while the 40% PEODM constructs contained 6.5% per wet weight at 7 weeks with
no statistically significant difference among the various % PEODM observed (Figure 4.7,
Table 4.3). Both the total collagen and GAG contents increased with time. In addition
there was a statistically significant interaction between time and % PEODM for collagen.
As time increased the difference among PEODM groups also increased with 40%
PEODM having the largest total collagen value. The DNA contents (millions of cells per
mg wet weight) remained constant with time and polymer composition (Tables 4.2 and
4.3). The percent of Type II collagen present after 6 weeks of subcutaneous implantation
was 35% (± 11) (Figure 4.8).
4.4.3 Histology. Safranin 0 stained tissue sections of the 10, 20, 30 and 40% PEODM
constructs demonstrated a distribution of GAG, a product of differentiated chondrocytes,
throughout the constructs (7 weeks, Figure 4.9a-d). The tissue structure is characteristic
of cartilage including ovoid shaped cells surrounded by an extracellular matrix.
Mitotically active cells are observed in all tissue sections. Control constructs of polymer
without chondrocytes were acellular with a thin, fibrous capsule surrounding the implant
(H&E staining, not shown).
4.5 Discussion
Photopolymerization is a technique used frequently in dentistry to form sealants
and dental restorations in situ. 1 4 Photopolymerization has been utilized to form
hydrogels for preventing post-surgical adhesions and restenosis after angioplasty. 15, 16
From a tissue engineering implantation perspective, photopolymerization provides a fast
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b.)
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c.)
d.)
Figure 4.9. Safranin 0 stained histological sections of a.) 10%, b.) 20%, c.) 30% and d.)
40% PEODM constructs harvested after 7 weeks (200 X).
99
and efficient method to form a solid hydrogel from a liquid polymer solution in vivo.
Transdermal photopolymerization provides physicians with a method to inject and mold
synthetic implants and create autologous cartilage through tissue engineering in a
minimally invasive manner.
In this study, PEO endcapped with methacrylate groups, PEODM, was utilized as a
photocrosslinkable macromer. Radicals produced by a photoinitiator react with the
methacrylate groups to cause polymerization leading to hydrogel formation or conversion
of the liquid polymer solution to a solid network. A wide range of wavelengths of light
can be used to cause a photopolymerization. By addition of an appropriate photoinitiator,
visible light or UVA light can used to photopolymerize a polymer. UVB light has limited
tissue penetration and may potentially damage tissue. UVA light was chosen for
transdermal photopolymerization due to the high efficiency of UVA photoinitiators,
allowing hydrogel formation beneath tissue to occur faster and with less intense light.
Light is attenuated by skin. Thus, the depth of implantation plays a critical role in
determining the exposure time required to cause hydrogel formation as described in
Chapter 2.17 Increasing the depth of implantation, or the thickness of skin that the light
must penetrate, increases the time of light exposure and the intensity of light required to
photopolymerize the polymer. The light intensity and exposure time necessary to
transdermally photopolymerize an implant under varying thickness of skin were modeled
in Chapter 2.17 Only three minutes of exposure to 2 mW/cm 2 UVA light, an intensity
comparable to commercial tanning bed lamps, is required to convert a liquid PEODM
polymer solution to a solid hydrogel subcutaneously in the mice used in this study. The
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experimental technique of polymer/cell injection and photopolymerization is shown in
Figure 4.1.
Photopolymerization or hydrogel formation may be controlled by the duration,
intensity, and time of exposure of the polymer to light. For example, spatial resolution
may be accomplished by simply exposing part of the liquid polymer to light. Temporal
control may be attained by simply removing or supplying the light source. Finally, the
ability to cause a photopolymerization through the skin provides a minimally invasive
technique to implant hydrogel constructs by simply injecting a viscous, photocurable
solution through a needle. Figures 4.3 and 4.4 demonstrate an athymic mouse during
transdermal photopolymerization and the resulting implants.
The objective of this study was to determine if chondrocytes could survive injection
and photopolymerization in PEO-based hydrogels and form tissue including an
extracellular matrix comparable to natural cartilage. In particular, the effect of increasing
the crosslinking density (i.e., increasing PEODM content) on cartilage formation was
studied (see experimental protocol, Figure 4.2). The PEODM is the crosslinking
macromer and thereby controls the crosslinking density and mechanical properties of the
final gel. The PEO serves to increase the viscosity of the solution to facilitate injection
and help maintain an open pore structure for cell encapsulation. Thus, the content of
PEODM in the hydrogels plays an important role in the water content and mechanical
integrity of the resulting semi-IPN that is formed while the PEO serves to aid nutrient and
waste transport. The 10 and 20% PEODM semi-IPNS -exhibit little resistance to palpation
when injected subcutaneously and photopolymerized, similar to solutions of pure,
uncrosslinked PEO. The 30% network begins to show maintenance of structure upon
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palpation, while the 40% PEODM shows good resistance to compression upon palpation
after polymerization. These gross in vivo observations were confirmed by equilibrium
swelling volumes that were determined in vitro. The equilibrium swelling volume, Q, is
a function of the water content of the network and provides information regarding the
crosslinking density and mechanical properties. 1 8 The 10 and 20% networks dissolved
completely in PBS, therefore swelling could not be observed. The 30 and 40% networks
exhibited increasing equilibrium swelling (larger pore size and higher water content) than
100% PEODM hydrogels (Table 4.1).
The nude mouse model has been used extensively in the field of tissue engineering to
study the potential of new biomaterials in vivo. 7 , 19 Bovine chondrocytes were utilized
with the nude mouse model since large numbers of cells can be readily obtained. The
total amounts of GAG and collagen in the tissue engineered neocartilage were similar to
cartilage synthesized in bioreactors on PGA scaffolds in vitro and cartilage formed in
vivo using PEO alone. 7' 19 The fraction of type II collagen was reduced compared to
native articular cartilage. While GAG contents decreased with increasing PEODM, total
collagen increased, suggesting that the more mechanically stable networks with a higher
crosslinking density (40% PEODM) may be utilized as scaffolds for neocartilage
formation.
The tissue structure observed in the histology sections resemble neocartilage for all of
polymer compositions studied and demonstrate a heterogeneous cell population (Figure
4.9). Cells are ovoid or elongated and trapped in lacunae similar to natural neocartilage.
Control polymer implants showed no evidence of cartilage suggesting that cartilage
formed from encapsulated chondrocytes and cell recruitment did not occur. Control
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polymers demonstrated a typical foreign body response comprised of macrophages and
giant cells in a fibrous capsule surrounding the implant. The presence of elongated cells
(and the ratio of type I versus II collagen) is suggestive of partial dedifferentiation of the
articular chondrocytes to fibrochondrocytes. Normal articular cartilage produces only
type II collagen. Ectopic (subcutaneous) implantation of the constructs may be the cause
of the cartilage dedifferentiation. Normal articular cartilage is exposed to mechanical
forces and growth factors in the joint, which help to maintain the structure and function
of the cartilage. The lack of presence of these stimuli, both mechanical and chemical, in
the ectopic (subcutaneous) site of implantation may be responsible for the
dedifferentiation of the tissue-engineered neocartilage. Mitotic (dividing) cells are
observed in all sections (Figure 4.9). The PEODM network, most notably in the 30 and
40% PEODM polymer compositions, stained violet (Figure 4.9c,d). Chondrocytes
trapped within the polymer present in the 40% PEODM constructs are viable. Necrosis is
not observed.
4.5 Conclusion
Transdermal photopolymerization provides a minimally invasive method for
injectable implantation of a hydrogel network. Chondrocytes survive encapsulation and
subcutaneous implantation using photopolymerization and produce extracellular matrix
forming neocartilage. The GAG and total collagen content of the neocartilage are similar
to other tissue-engineered cartilage after 6 weeks of subcutaneous implantation. Future
research is aimed at determining the maximal PEODM content where cell and tissue
viability is maintained and studying the effects of long term implantation on the cartilage
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implants. In addition, other cell types may be encapsulated to engineer other tissues in a
similar fashion.
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Chapter 5. Controlled-Release of Growth Factors in Photopolymerized
Hydrogels*.
5.1 Introduction
The previous two chapters examined the ability to tissue engineer cartilage in a
photopolymerizing hydrogel both in vitro and in vivo. While cartilage-like tissue formed,
the collagen contents, particularly in in vitro samples, were far below those of native
cartilage. Growth factors help form and maintain normal articular cartilage and may prove
useful in stimulating matrix production. This chapter examines 1.) the ability to
encapsulate growth factors in PLGA microspheres and 2.) the effects of encapsulated
growth factors on cartilage formation in photopolymerized hydrogels.
5.2 Background
Insulin-like growth factor (IGF) exerts anabolic effects on cells of mesenchymal
origin, particularly fibroblasts and chondrocytes.1 IGF causes cell proliferation and
extracellular matrix (ECM) synthesis, both crucial processes for cartilage tissue
engineering. IGF is synthesized locally within chondrocytes and is stored in the ECM.
IGF interacts with other growth factors, including synergistic interactions with epidermal
growth factor (EGF). Of particular interest to cartilage homeostasis in vivo and cartilage
tissue engineering is the synergistic effects between IGF and transforming growth factor-
beta (TGF-b). 2
TGF-b has many biological actions. In vitro effects of TGF-b have been difficult
to ascertain due to often-contradictory results. 1 In cartilage TGF-b inhibits cell
This chapter will be submitted in part for publication in a peer-reviewed journal.
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proliferation and stimulates ECM production.1 The inhibition in cell proliferation was
overcome when IGF and TGF were combined in vitro. Tsukazaki et al found a
synergistic effect of IGF-1 and TGF-b, causing a 10-fold increase in DNA synthesis on
plated chondrocytes when present in a 25:1 (ng/ml) ratio. 3 This synergy was studied in
an experimental group in this chapter.
The ability to mimic the native local environment of a chondrocyte may be aided
by the addition of growth factors to a tissue engineering scaffold system. Growth factors
can be added to a system using a variety of methods. 4 A growth factor may be
incorporated into a tissue engineering scaffold via encapsulation in polymer fibers or
matrix. The growth factor may also be covalently attached to the scaffold using a variety
of chemistries. The kinetics of growth factor release in a system is another critical factor
in obtaining the desired effect of a growth factor. Cellular responses may differ when a
bolus versus controlled release growth factor is presented. 5
Polymeric microspheres can release proteins over an extended period of time
(controlled release). 6 Poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres have been
used extensively for controlled release with tissue compatibility and biodegradability. 7
Microspheres are injectable and release in a localized site. These two properties are
important for their use in the photopolymerizing hydrogel system. First, the hydrogel
system was developed to provide a minimally invasive cartilage tissue engineering system
that can be implanted through an injection. Microspheres could be injected and
photopolymerized with the polymer hydrogel system. Second, local delivery of growth
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factors is crucial since these proteins often have short half-lives and multiple biological
effects with potential systemic toxicity. 4 The purpose of this work was to 1.) release
growth factors in a controlled release manner in the photopolymerizing hydrogel and 2.)
examine the effects of the growth factors on encapsulated chondrocytes.
5.3 Methods
5.3.1. Microsphere Preparation. Microspheres were prepared by a double emulsion
technique. 8 Two hundred mg poly(lactic acid-co-glycolic acid), PLGA 50:50 was
dissolved in 1 ml of methylene chloride. IGF-l (50, 100 and 200 jtl of 10 tg IGF-1/ml
stock, R&D Systems, 612) and TGF-b (100 of 1 jig TGF-b/ml stock, R&D Systems)
were added to the PLGA solution. These microsphere groups will subsequently be
referred to as IGF50, IGFlOO, IGF200 and TGF100 respectively. One group included a
combination of IGF100 and TGF100 microspheres (IGF/TGF) in a 25:1 ratio at a
concentration of 15 mg/ml of microspheres. The IGF-1 stock solution was 10 mM acetic
acid with 0.1% bovine serum albumin. The TGF-b stock solution was 4 mM HCI and I
mg/ml bovine serum albumin. The polymer and growth factor were sonicated on ice for 6
pulses, 50% duty output 3 microtip (Vibracell, Danbury, CT). This primary emulsion
was then added to a 1 00-mL aqueous solution of 1% (w/v) poly(vinyl alcohol) (PVA).
The second emulsion was formed by homogenization for 1 min at 3,000 rpm on a
Silverson (East Longmeadow, MA) homogenizer using a 5/8" micro-mixing assembly with
a general with a general-purpose disintegrating head. The resultant water-in-oil-in-water
(w/o)/w emulsion was stirred continuously for 3 h for solvent evaporation. The hardened
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spheres were centrifuged, washed 3 times with distilled water and freeze dried for 48
hours and stored under desiccant at -20'C.
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Figure 5.1. Schematic ofmicrosphere encapsulation and experiment.
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Microsphere loading was determined by protein assay. Approximately 10 mg of
microspheres were degraded in 2 ml of 0. IN NaOH and 0.5% SDS on an orbital shaker at
37'C overnight. Protein content was subsequently determined by a micro BCA protein
assay (Pierce, Rockford, IL).
Release. Approximately 10 mg of microspheres were placed in Eppendorf vials with 1 ml
PBS. The spheres were incubated statically at 370 C. The PBS was removed, frozen and
replenished at 1, 2, 5, 10 and 15 days. ELISAs (enzyme linked immunosorbant assay) for
IGF-1 (Oxford Diagnostics) and TGF-b (R&D Systems) were performed on the spent
PBS to determine the concentration of active protein released. Blank microspheres
(containing PBS in place of growth factor stock) were synthesized and released as
controls.
5.3.2. Chondrocyte Encpasulation. PEODM (MW 3400, Shearwater Polymers) and
PEO (MW 100,000, Shearwater Polymers) were dissolved in PBS in a 2:3 ratio (40%
PEODM) to make a final polymer concentration of 20% (w/v) in phosphate buffered
saline (PBS). Photoinitiator (hydroxycyclohexyl phenyl ketone, HPK, Polysciences,
Warrington, PA) was added to make a final concentration of 0.03% (w/v). Primary
bovine chondrocytes were harvested and isolated from the calf femoropatellar groove as
described. (Chapter 3) The polymer solution was added to a cell pellet to make a final
concentration of 50xi 06 cells/cc.
IGF, TGF and FGF were dissolved in the PEODM polymer and cell suspension
at concentrations of 50, 30 and 3 ng/ml, respectively. The cells and growth factor and
polymer were photopolymerized as described previously in Chapter 3. Constructs were
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incubated under static conditions at 37'C. Specimens were removed for biochemical
analysis at 3, 9 and 18 days.
Fifteen milligrams of microspheres were suspended and mixed in 1 ml of
polymer/cell solution. Control groups included polymer without cells or microspheres,
polymer with chondrocytes and no microspheres, and polymer with cells and blank
spheres. Experimental growth factor groups included IGF 100, IGF200, TGF200 and
IGF/TGF spheres combined in a 25:1 ratio. The polymer/cell suspension was mixed on a
rotating plate for one hour. The suspension was subsequently aliquoted (150 jtl) in
sterile Eppendorfs. The solutions were photopolymerized by placement under a UVA
lamp (Glomark Systems, Upper Saddle River, NJ). The lamp was at a height such that
the solutions received 1.5 mW/cm 2 for 3 minutes as measured by a radiometer. All
constructs were incubated in 12-well tissue culture plates with complete media (high
glucose DMEM, 10% FBS, 10 gg/ml vitamin C, 12.5 mM HEPES, 0.1 mM nonessential
amino acids and 0.4 mM proline) at 37C/5% CO2 under static conditions.
Constructs were removed at 3, 7, 10 and 14 days for the IGF spheres (n=4-6) and
at 14 days only for the TGF and TGF/IGF spheres (n=4). Constructs were removed from
the tissue culture plates, blotted dry and wet weights (ww) were obtained. Gels were
subsequently lyophilized for at least 48 hours after which dry weights (dw) were
determined. The hydrogels were digested in 1 ml papainase overnight at 60C . GAG
content was estimated by chondroitin sulfate using dimethylene blue dye and a UV-VIS
spectrophotometer. 9 Total collagen content was determined by the hydroxyproline
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determined after acid hydrolysis and reaction with p-dimethylaminobenzaldehyde and
chloramine-T using 0.1 as the ratio of hydroxyproline to collagen. 10 The cell content of
the hydrogels was determined using Hoechst 33258, spectrofluorometry and a conversion
factor of 7.7 pg DNA per chondrocyte. 11 At specified time points, constructs were
removed from the wells. The constructs were blotted dry and weighed to obtain wet
weights. After two days of vacuum drying construct dry weights were obtained. The
dried constructs were digested with papain and frozen for analysis. GAG, DNA and
collagen contents were determined using DMMB dye, fluroscopy and hydroxyproline
contents, respectively, as described. 9 , 11 Histology was prepared according to standard
histological technique.
One and two-way ANOVA analysis of variance was performed using Minitab
Software.
5.4 Results
5.4.1. Release. The cumulative release of IGF was dependent on the initial microsphere
loading. The release curves for both IGFl and TGFb exhibited no initial bursts. The
IGF1 spheres loaded with lower concentrations of growth factor demonstrated a release
plateau after one week whereas the IGF200 and TGFb spheres showed continued release
over the two-week time period studied. The IGF200 microspheres released 125 ng/ml of
active IGF over 15 days, more than double the IGF 100 spheres that released 55 ng/ml
over the same time period (Figure 5.2). The TGF spheres released 200 pg/ml of active
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protein over 15 days (Figure 5.3). The total protein loading of the IGF and TGF
microspheres was 14.95+0.72 and 0.48+0.13 ng/mg respectively.
5.4.2. Chondrocyte Encapsulation. Gels made with 15 mg/ml of microspheres were
similar in form to control gels without microspheres except for increased opacity from the
microspheres. Microspheres encapsulated at a concentration of 30 mg/ml interfered with
hydrogel formation, producing gels that were not as mechanically stable as control gels
and those synthesized with 15 mg/ml.
GAG and total collagen contents increased over the two-week incubation period.
GAG contents among the experimental groups were similar over the first three time
points up to 10 days. A statistically significant increase in GAG between control
constructs and those with 15 mg/ml IGF100 microspheres was present after 14 days
(p=0.013, Figure 5.4). The total collagen contents did not differ
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Figure 5.2. Cumulative release of IGF-1 from PLGA microspheres
prepared with 50 (--S--), 100 (--Y--) and 200 ul (-0--) of stock.
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Figure 5.3. Cumulative release of TGF-b from PLGA microspheres.
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between the polymer, blank, 15 and 30 mg/ml groups over the two weeks studied
(p=0.22, Figure 5.5). There was a significant decrease in DNA content from 3 to 7 days
in all of the experimental groups (p=0.04). The DNA content appeared to stabilize after
one week with no significant decreases among any group found from 7 to 14 days
(p=0. 4 0, Figure 5.6).
Further experimental groups studied showed a significant increase in GAG
production at 14 days in the (IGF/TGF, p=0.04, Figure 5.7). A decreased total collagen
content was observed in the IGF/TGF group (Figure 5.8). The IGF/TGF group showed a
significantly increased DNA content (Table 5.1). All other experimental groups had
similar total collagen and cell contents.
Figure 5.9(a-e) demonstrates histological sections of the tissues formed after 14
days of incubation. Figure 5.9a shows the encapsulated chondrocytes with no
microspheres present. Ovoid and elongated cells are distributed within an extracellular
matrix. The extracellular matrix is lightly basophilic. As described in Chapter 3, the cells
show multiple cell distributions with areas of dense cellularity characteristic of cartilage
and areas of low cell dispersion. Figures 5.9b and c show cells encapsulated with IGF
microspheres. No gross difference with the polymer alone (Figure 5.9a) or blank
microspheres (section not shown) is apparent. The microspheres can be easily seen on
higher magnification (Figure 5.9c). A large difference in matrix staining is observed in the
IGF/TGF encapsulated cells (Figures 5.9d-e). The pericellular regions show an increased
basophilic staining. Furthermore, there appears to be a more even (and dense) cell
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distribution compared to the other sections. Entrapped bubbles are observed as round,
clear regions (Figures 5.9d and 3).
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Figure 5.4. Evolution of %GAG with time for hydrogel control, blank
spheres, 15 and 30 mg/ml IGF100 spheres.
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Figure 5.5. Evolution of %total collagen with time for hydrogel control,
blank spheres, 15 and 30 mg/ml IGF100 spheres.
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Figure 5.6. Cell content of constructs for hydrogel control, blank spheres,
15 and 30 mg/ml IGF 100 spheres.
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Figure 5.7. Comparison of % GAG among growth factor groups at 14 days.
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Figure 5.9. H&E sections of day 14 tissue polymerized with a.) no microspheres (IOOX),
b.) IGF100 microspheres LOOX, and c.) 400X, d.) IGF/TGF microspheres (100X)
and e.) 200X.
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5.5 Discussion
Chondrocytes experience biochemical and mechanical stimulation in vivo that are
integral to the development and maintenance of cartilage. 12 Mechanical forces stimulate
chondrocytes to produce and maintain their extracellular matrix.1 3 Long-term disuse of a
joint can lead to atrophy. Growth factors aid in signaling and regulating cartilage
development and extracellular matrix maintenance. 14 Growth factors are stored in the
matrix for immediate release when needed. Similarly, the purpose of this work was to
store growth factors in a synthetic matrix in the form of microspheres to aid in cartilage
development in photopolymerized hydrogels.
Polymeric microspheres serve a critical role in a variety of biomedical
applications, providing localized, controlled delivery of sensitive molecules such as
growth factors.7 TGF-beta and basic fibroblast growth factor (bFGF) have been
encapsulated in polymeric microspheres to study cellular response in vascular tissue
engineering. 5 To our knowledge, IGF-I has not been encapsulated in a microsphere
system. IGF-I has a multitude of clinical applications that may be better served with a
controlled release delivery system.1 5 , 16
The PEO-based hydrogels that were utilized for photoencapsulation must have
porous structure large enough to allow nutrient and waste transport for cell metabolism.
See swelling (Chapter 4) and mechanical (Chapter 3) data. Small proteins, such as growth
factors, can easily diffuse in the hydrogel matrix. IGF 1 and TGFb encapsulated directly
in the hydrogel provided no benefit to GAG and DNA concentrations over 18 days (data
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not shown). For this reason microspheres were embedded in the hydrogel to provide
controlled release of relevant growth factors for encapsulated chondrocytes. The
concentration of growth factor may be easily changed by the amount of microspheres
encapsulated.
Differences in GAG production appear after two weeks of in vitro incubation.
Differences of over 2% (ww) GAG are observed with IGF 100 and IGF I /TGFb
microsphere groups compared to controls. On the other hand, collagen levels remain low.
While differences in mean collagen between experimental groups appear to be increasing
with the largest difference apparent at 14 days, no statistical difference was observed.
Longer incubations may find a positive effect of IGF 1 or TGFb on collagen production.
DNA contents decreased over the experimental time period. This decrease in
DNA content was discussed in Chapter 3. The most significant growth factor effect was
on the DNA content in hydrogels with IGFI and TGFb microspheres. The microspheres
were combined in a ratio (25:1) found to increase DNA synthesis 10-fold. 3 The
photoencapsulated cells showed a similar 10-fold increase in cell content. While the GAG
content in these hydrogels was significantly above control gels, the collagen content was
significantly lower. The chondrocytes encapsulated with IGF 1 /TGFb spheres were
stimulated to multiply but at the expense of matrix synthesis. The histological sections
of the IGF I/TGFb constructs provide information on the potential matrix production.
Histologically the IGF1/TGFb constructs show marked differences from controls
and IGF1 constructs. The increased cell content can be visually confirmed in the
IGF l/TGFb sections. More importantly, the pericellular region of the chondrocytes
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stained strongly for proteoglycan synthesis. This increased pericellular staining suggests
that the chodrocytes are actively producing matrix. Thus, it may be hypothesized that
longer incubation may demonstrate a significant increase in GAG and collagen production
in the IGFl/TGFb constructs.
Rigorous mixing is important for proper cell distribution within the viscous
prepolymer solution. The addition of microspheres to the prepolymer further increases
the necessity for proper mixing before polymerization. Mixing (via pipette, vortex or
manual stirring) causes air bubbles in the viscous prepolymer solution. Due to the high
viscosity of the prepolymer solution, these air bubbles may still be present during
photopolymerization. The histology sections (Figure 5.9) demonstrate air bubbles
trapped during polymerization. These bubbles demonstrate interesting properties of the
hydrogel. First, the shape of the small bubbles is maintained by the hydrogel after
polymerization. Second, the tissue maintains the shape of the hydrogel scaffold and does
not grow into the bubble space. This suggests that the hydrogel may be used to tissue
engineer complex shapes. For example, air bubbles of different sizes may be forced into
the prepolymer using airflow at different rates and photopolymerized. This would create
a hydrogel with a large porous structure in addition to the microscopic pores formed by
the polymer chains. Cells may be encapsulated during the photopolymerization and/or
cells could be seeded on the large pores.
Further study should focus on optimizing the growth factor release characteristics
for chondrocyte division when cells are initially encapsulated and subsequent matrix
synthesis. For example, an initial or periodic burst of a combination of growth factors
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may stimulate increased matrix production. Increased collagen production would be
highly beneficial to the constructs since their collagen content was far below native values.
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Chapter 6. Conclusions, Implications and Future Work
The aims of this thesis were to 1.) develop, describe and test a novel, minimally
invasive method for implanting hydrogels which has been termed transdermal
photopolymerization and 2.) apply transdermal photopolymerization to engineering
cartilage tissue. The results described in this dissertation demonstrate the feasibility and
efficacy of transdermal photopolymerization. Various biomedical applications of
transdermal photopolymerization, including tissue engineering, were examined.
Conclusions
Transdermal Photopolymerization. The studies in this thesis have demonstrated the
feasibility of transdermal photopolymerization. Photopolymerization can proceed under
tissues with thickness comparable to those found in humans. Polymerization times
determined by kinetic analysis are clinically feasible, with only minutes of light exposure
required to polymerize. Toxicity studies yielded the conditions required to successfully
encapsulate cells with undetected or minimal damage. Further in vivo work demonstrated
the feasibility and biocompatibility of transdermal photopolymerization in mice and rats.
Cartilage Tissue Engineering. Initial photoencapsulation experiments demonstrated cell
survival during the photoencapsulation. Further analysis of the hydrogels incubated in
vitro demonstrated extracellular matrix deposition that increased over time. In addition,
the matrix increased in mechanical function.
Growth factors relevant to cartilage development and maintenance were released
from synthetic microspheres embedded in the hydrogel. The presence of the growth
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factors in the hydrogel increased DNA and GAG contents but did not significantly alter
collagen contents.
The potential of cartilage tissue engineering using transdermal
photopolymerization was further demonstrated by the production of cartilage-like tissue
in vivo. SemiIPNs implanted subcutaneous in athymic mice increased extracellular
matrix (GAG and collagen) over the 7 week time period studied.
Implications and Future Work
As described in Chapter 2, the development of transdermal of transdermal
photopolymerization has a wide range of applications. Drug delivery and tissue
engineering applications were examined in this thesis, with a focus on cartilage tissue
engineering. The hydrogel matrix may be ideal for engineering other tissue types. Pilot
experiments have also been performed using the photopolymerizing hydrogel as a
"living" cartilage glue. Tissue engineered, autologous or allogenic cartilage that is placed
in a cartilage defect must integrate with the host cartilage to become fully functional.
The hydrogel may act as a glue to prevent implant movement. Cells present in the
hydrogel would help form tissue in the gap region between the two pieces of cartilage,
promoting integration.
A wide range of photoreactive polymers and photoinitiators may be applied to the
technique of transdermal photopolymerization. This opens further questions to the choice
of scaffold (polymer) and the biology of the chondrocyte interaction with the gel. The
interactions of cells entrapped within a gel may be different than those seeded on a gel or
solid scaffold. The morphology, gene expression, and general biology of cells entrapped
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within a gel should be examined. In particular, varying the chemistry of the gel
entrapping the chondrocytes and analyzing the subsequent cell biology may provide
useful insight for cartilage development and engineering. Potential chemistry alterations
to the gel system are numerous.
As described in Chapter 2, visible light penetrates tissue more easily than UVA
light. Defining efficient visible light photoinitiating systems may allow use of visible
light for transdermal photopolymerization. Analysis of biocompatibility and kinetics of
new visible light initiating systems is necessary for the efficient use of transdermal
photopolymerization for hydrogel implantation.
In order for the clinical application of transdermal photopolymerization and
photoencapsulation, further toxicity issues should be examined. While this thesis
examined potential radical damage to cell membranes, further work should probe other
possible mutations. Potential protein oxidation and DNA damage in encapsulated cells
and cells adjacent to the implant should be studied. For example, the presence of mutated
bases or unscheduled DNA synthesis may be analyzed.
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Appendix A. Kinetic program used for photopolymerization modeling.
C KINETIC PROGRAM WITH DARK POLYMERIZATION BUT NO PULSE
C Makes thin film approximation for initiation
c
c Kinetic modelling of the polymerization reaction
involving systems
c exhibiting a gel effect and prediction of the
c kinetic constants of the system as a function of the
free volume of
c the system.
c
c
c Variable description:
c
c Kinetic constants:
c
c Ksubp
of free volu
- kinetic constant for propagation, function
c KsubpQ - parameter for determining ksubp
c vsubfO - critical free volume for ksubp
c Vstar - parameter for determination of ksubp
c Ksubt - kinetic constant for termination, function
of free volu
c KsubtQ - parameter for determining ksubt
c vsubfc - critical free volume for ksubt
c A - parameter for determination of ksubt
c ratio - parameter that relates the reaction
diffusion resistance
c to the propagation reaction
c
c Volume contraction and free volume:
c
c vsubf
of time
c vsubfeq
conversion
- actual free volume of the system, function
- equilibrium free volume, function of
c v - specific volume
c vm - monomer specific volume
c vp - polymer specific volume
c epsilon - fractional change in volume from monomer
to polymer
c veq - equilibrium specific volume, assumed
linear with conver
c phip - polymer volume fraction
c alpham - thermal expansion coefficient of the
monomer
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c alphap - thermal expansion coefficient pf the
polymer
c glasstm - glass transition temperature of the
monomer (celcius)
c glasstp - glass transition temperature of the
polymer (celcius)
c
c Reaction concentrations and conditions:
c
c concI - initiator concentration
c concIO - initial initiator concentration
c concM - monomer concentration
c concMO - initial monomer concentration
c concMr - concentration of growing polymer radicals
c concrr - concentration of initiator radicals
c time - reaction time in seconds
c timetot - total time of reaction observation
c timeinc - length of time in each finite difference
c ntime - total number of time increments
c temp - reaction temperature
c X - conversion
c f - initiator efficiency
c
c Dummy variables:
c
c R
c S
c
c
c
c Begin Program
c
c Declarations
c
DOUBLE PRECISION
KSUBPKSUBTKSUBI,V, VEQVSUBFVSUBFETAUCONCI
DOUBLE PRECISION
CONCM, X,PHIP, TIMEIC,CONCMR,TIME,RATEV
DOUBLE PRECISION
AA,Vi,EPSI,TIMIC2, TIMED,VX,V2, TAUl,TAU2
DOUBLE PRECISION KEFF
REAL ti,rv,rtconv,freev,kt,kp
REAL KSUBPO,VSUBFO,VSTAR,KSUBTOVSUBFC,A,IO
REAL ATAU,BTAU,ALPHAM,ALPHAP,GLASTM,GLASTP
REAL CONCO2,TEMP,VM,VP,CONCIO,CONCMO
REAL XCSUBP,XCSUBT,EPSILO,CONO20,F,RATIO
INTEGER I,TIMETO,MM,K,L,M,nnn
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cc
c Input Section
c
c
READ *, KSUBPOVSUBFOVSTAR
WRITE (*,*)- KSUBPO,VSUBFOVSTAR
READ *, KSUBTO,VSUBFC,A,RATIO
WRITE (*,*) KSUBTO,VSUBFC,A,RATIO
READ *, IO,EPSI
WRITE (*,*) IO,EPSI
READ *, VM,VP
WRITE (*,*) VM,VP
READ *,ALPHAM,ALPHAP
READ *,GLASTM, GLASTP, TEMP
READ *,CONCIO,CONCMO
READ *,TIMETO,TIMEIC
READ *,F
READ *, TIMED
WRITE (*,*) ALPHAM,ALPHAP
WRITE (*,*) GLASTM,GLASTP,TEMP
WRITE (*,*) CONCIO,CONCMO,CONO20
WRITE (*,*) TIMETO,TIMEIC
WRITE (*,*) F
WRITE (*,*) TIMED
WRITE (*,*)
WRITE (*,*) RATIO, VSUBFO
C
C
C INITIALIZATION
C
C
XINC = 0.01
V =VM
Vi = AFRAC*VM
V2 = (1.-AFRAC)*VM
x = 0.
CONCM = CONCMO
CONCI = CONCIO
CONCMR = 0.
CONCO2 = CONO20
KSUBP = KSUBPO
KSUBT = KSUBTO
TIME = 0.
RATE = 0.
MM = 0
VEQ = VM
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VSUBFE = 0.025 + ALPHAM*(TEMP-GLASTM)
VSUBF = VSUBFE
NPRINT = 5000
WRITE (*,100) TIMEX,CONCMRRATEQSSHVVEQ
,VSUBF, VSUBFE
C
C
C CALCULATIONS
C
C
EPSILO = (VM-VP)/VM
TIMIC2 = TIMEIC*250.
C
C
c BEGIN CALCULATION LOOP
C
C
3 CONTINUE
TIME = TIME + TIMEIC
C
C DETERMINATION OF V AND VSUBF
C
NT = NT + 1
X = 1. - CONCM/CONCMO
VEQ = VM*(1. - EPSILO*X)
PHIP X* (1.-EPSILO) / (1.-EPSILO*X)
VSUBFE = 0.025 + ALPHAM*(TEMP-GLASTM)*(1.-PHIP)
A +ALPHAP*(TEMP-GLASTP)*PHIP
VSUBF = VSUBFE
C
C DETERMINATION OF KINETIC CONSTANTS
C
KSUBP = KSUBPO * (1.0+1.0/EXP(-VSTAR*
c (1./VSUBF-1./VSUBFO)))**-1.0
KSUBT = KSUBTO * ((((RAT IO*KSUBP*CONCM/KSUBTO
C + EXP(-A*(1./VSUBF-1./VSUBFC)))**-1.0)
C + 1.0)**-1.0)
KEFF = KSUBP/(KSUBT**0.5)
VX = V
C
C DETERMINATION OF CONCENTRATIONS --
C
AA = IO*3.0512E-06*EPSI*CONCI*TIMEIC
CONCI = CONCI-AA
CONCMR = CONCMR*(1.-
KSUBT*CONCMR*TIMEIC*2. ) +2.*AA*F
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QSSH = (-
CONCMR*KSUBT*CONCMR*TIMEIC*2.+2.*AA*F)/AA/2./F
CONCM = CONCM -(KSUBP*CONCM*CONCMR)*TIMEIC
XX = KSUBP*CONCM*CONCMR*TIMEIC
IF (XX.GT.XMAX) THEN
XMAX = XX
ELSEIF -(XX.LT.XMAX/100.) THEN
TIMEIC = TIMIC2
XINC = 0.005
ENDIF
IF (TIME.GT.TIMED) THEN
10 = 0.
ENDIF
MM = MM + 1
C IF (NT.GT.NPRINT) THEN
IF (X.GT.XPRINT) THEN
XPRINT = X + XINC
NT = 0
RATE = 100.*(KSUBP*CONCM*CONCMR)/CONCMO
RATEV = 100.*(VX-V)/TIMEIC/(VM-VP)
MM = 0
WRITE (*,100) TIME,X,RATE,VSUBF,KSUBP,KSUBT
IF (X.GT.0.995) GO TO 85
ENDIF
IF (TIME.LT.TIMETO) GO TO 3
100 FORMAT (1X,F8.4,3(1X,F7.4),2(1X,e12.3))
85 RATE = 100.*(KSUBP*CONCM*CONCMR)/CONCMO
RATEV = 100.*(VX-V)/TIMEIC/(VM-VP)
WRITE (*,100) TIME, X, RATE,VSUBF, KSUBP,KSUBT
END
105 0.035 0.50
5.0e6 0.099 12.0 1
0.1060 150
0.93 0.86
0.0005 0.000075
-100 55 30
0.004141 1.0
3000 0.01
1.0
10000
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Appendix B. Abbreviations
TDP: Transdermal Photopolymerization
PEODM: Poly(ethylene oxide) dimethacrylate
PEG: Poly(ethylene glycol)
HPK: 1 -Hydroxycyclohexyl phenyl ketone
GAG: glycosaminoglycans
MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide
MW: Molecular Weight
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